Archives

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
Tesla's Tumble Nears Its End, Benchmark Analyst Foresees Rebound Ahead
Market Updates

Tesla's Tumble Nears Its End, Benchmark Analyst Foresees Rebound Ahead

April 14 - Tesla (NASDAQ:TSLA) has lost nearly half its value since peaking in December, but Benchmark analyst Mickey Legg believes the downturn may be short-lived.Tesla's Tumble Nears Its End, Benchm...

  • April 14, 2025 05:22 AM PDT
  • EODHD
Certara Launches Non-Animal Navigator™ Solution to Help Drug Developers Reduce Reliance on Animal Testing
Market Updates

Certara Launches Non-Animal Navigator™ Solution to Help Drug Developers Reduce Reliance on Animal Testing

RADNOR, Pa., April 14, 2025 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development, today announced the launch of its Non-Animal Navigator™ solution desig...

  • April 14, 2025 05:15 AM PDT
  • EODHD
Class of 2025: Five Potential Challenges Facing Early Career Professionals--and How to Overcome Them
Market Updates

Class of 2025: Five Potential Challenges Facing Early Career Professionals--and How to Overcome Them

MENLO PARK, Calif., April 14, 2025 /PRNewswire/ -- As the class of 2025 prepares to enter the workforce, new research from talent solutions and business consulting firm Robert Half highlights the top...

  • April 14, 2025 05:05 AM PDT
  • EODHD
MKS Instruments Announces First Quarter 2025 Earnings Conference Call
Market Updates

MKS Instruments Announces First Quarter 2025 Earnings Conference Call

MKS Instruments, Inc. ANDOVER, Mass., April 14, 2025 (GLOBE NEWSWIRE) -- MKS Instruments, Inc. (NASDAQ: MKSI), a global provider of enabling technologies that transform our world, today announced that...

  • April 14, 2025 05:00 AM PDT
  • EODHD
Schrödinger’s Statement Regarding FDA Plan to Phase Out Animal Testing Requirement for Monoclonal Antibodies and Other Drugs
Market Updates

Schrödinger’s Statement Regarding FDA Plan to Phase Out Animal Testing Requirement for Monoclonal Antibodies and Other Drugs

NEW YORK, April 14, 2025--(BUSINESS WIRE)--Schrödinger, Inc. (Nasdaq: SDGR) strongly supports the U.S. Food and Drug Administration’s (FDA) plan to reduce, refine or potentially replace current animal...

  • April 14, 2025 05:00 AM PDT
  • EODHD
All-New 2026 Hyundai Palisade's New York International Auto Show Debut to be Livestreamed
Market Updates

All-New 2026 Hyundai Palisade's New York International Auto Show Debut to be Livestreamed

Palisade's New York International Auto Show debut takes place on April 16 at 10:30 a.m. ET, and will be livestreamed on the official Hyundai USA YouTube channel: https://www.youtube.com/live/ulNt2Jsev...

  • April 14, 2025 05:00 AM PDT
  • EODHD
Full House Resorts Announces First Quarter Earnings Release Date
Market Updates

Full House Resorts Announces First Quarter Earnings Release Date

LAS VEGAS, April 14, 2025 (GLOBE NEWSWIRE) -- Full House Resorts (NASDAQ: FLL) announced today that it will report its first quarter 2025 financial results on Thursday, May 8, 2025, followed by a conf...

  • April 14, 2025 05:00 AM PDT
  • EODHD
Flywire to Announce First Quarter 2025 Results on May 6, 2025
Market Updates

Flywire to Announce First Quarter 2025 Results on May 6, 2025

Flywire Corporation BOSTON, April 14, 2025 (GLOBE NEWSWIRE) -- Today, Flywire Corporation (Flywire) (Nasdaq: FLYW), a global payments enablement and software company, announced that its first quarter...

  • April 14, 2025 05:00 AM PDT
  • EODHD
Fate Therapeutics Receives Regenerative Medicine Advanced Therapy (RMAT) Designation from FDA for FT819 to Treat Moderate to Severe Systemic Lupus Erythematosus (SLE)
Market Updates

Fate Therapeutics Receives Regenerative Medicine Advanced Therapy (RMAT) Designation from FDA for FT819 to Treat Moderate to Severe Systemic Lupus Erythematosus (SLE)

Fate Therapeutics, Inc. – Recognizes potential of off-the-shelf CAR T-cell therapy to address significant unmet need and enables increased dialogue with FDA throughout the development process – RMAT r...

  • April 14, 2025 05:00 AM PDT
  • EODHD
Blockchain Forum 2025 in Moscow: top reasons to visit the crypto event of the year
Press Release

Blockchain Forum 2025 in Moscow: top reasons to visit the crypto event of the year

On April 23-24, Moscow will host the highly anticipated 14th Blockchain Forum. This legendary global event brings together over 15,000 individuals from across the globe. Why you can’t miss Blockchain Forum 2025 Leading global industry leaders will come to the forum in Moscow for the first time since 2022 to share exclusive content, insights, and […]

  • April 14, 2025 04:55 AM PDT
  • Invezz